<i>PTGER4</i> promoter methylation may serve as an independent prognostic biomarker and is associated with response to hypomethylating agents in pediatric acute myeloid leukemia.
- DOI
- 10.3389/fphar.2026.1922446
- Published
- 2026-09-08
- Container
- Front Pharmacol
- Publisher
- Not recorded
- Open access
- no
Credibility signals
uncertain Score 51/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3389/fphar.2026.1922446,
title = {\<i\>PTGER4\</i\> promoter methylation may serve as an independent prognostic biomarker and is associated with response to hypomethylating agents in pediatric acute myeloid leukemia.},
author = {Xue YJ and Cao X and Yang Y and Wang Y and Zheng F and Lu AD and Jia YP and Zhang LP and Zeng HM.},
year = {2026},
journal = {Front Pharmacol},
doi = {10.3389/fphar.2026.1922446},
url = {https://doi.org/10.3389/fphar.2026.1922446}
}RIS
TY - JOUR TI - <i>PTGER4</i> promoter methylation may serve as an independent prognostic biomarker and is associated with response to hypomethylating agents in pediatric acute myeloid leukemia. AU - Xue YJ AU - Cao X AU - Yang Y AU - Wang Y AU - Zheng F AU - Lu AD AU - Jia YP AU - Zhang LP AU - Zeng HM. PY - 2026 JO - Front Pharmacol DO - 10.3389/fphar.2026.1922446 UR - https://doi.org/10.3389/fphar.2026.1922446 ER -
APA
YJ, X., X, C., Y, Y., Y, W., F, Z., AD, L., YP, J., LP, Z., & HM., Z. (2026). <i>PTGER4</i> promoter methylation may serve as an independent prognostic biomarker and is associated with response to hypomethylating agents in pediatric acute myeloid leukemia.. Front Pharmacol. https://doi.org/10.3389/fphar.2026.1922446
Source records
- europe-pmc · retrieved 2026-09-25T09:26:56.624Z
- doaj · retrieved 2026-09-25T09:26:56.611Z